Richard J. Hendrix - 01 Jun 2024 Form 4 Insider Report for Danimer Scientific, Inc. (DNMRQ)

Reporting relationship: Director
Issuer ticker: DNMRQ
Reported as of: 01 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Oct 2024, 16:30:03 UTC
Prior SEC filing: 15 Dec 2023
Next SEC filing: 10 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Richard J. Hendrix

Key filing fact

Richard J. Hendrix filed Form 4 for Danimer Scientific, Inc. (DNMRQ) on 16 Oct 2024.

Key facts

This page summarizes Richard J. Hendrix's Form 4 filing for Danimer Scientific, Inc. (DNMRQ).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 Oct 2024, 16:30.

Change

Previous filing in this sequence was filed on 15 Dec 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DNMR transaction Derivative

Stock Appreciation Rights

Award

Transaction value: $0
Shares: +250,000
Change %
Price: $0.000000
Shares after: 250,000
Date: 14 Oct 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 250,000
Exercise price: $0.5500
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These stock appreciation rights (SARs) to purchase shares of the Issuer's Class A common stock ("Common Stock") were granted to Reporting Person on October 4, 2024 under the Danimer Scientific, Inc. 2020 Long-Term Incentive Plan (the "Plan"). SARs to purchase 250,000 shares of the Issuer's Common Stock will vest and become exercisable on May 20, 2025 subject to recipient's continued service as a director of the Company.